Literature DB >> 30614877

Females Are More Resistant to Ischemia-Reperfusion-induced Intestinal Injury Than Males: A Human Study.

Inca H R Hundscheid1, Dirk H S M Schellekens1, Joep Grootjans1,2, Joep P M Derikx3, Wim A Buurman1,4, Cornelis H C Dejong1,5,6, Kaatje Lenaerts1.   

Abstract

BACKGROUND AND
OBJECTIVE: Sex differences in responses to intestinal ischemia-reperfusion (IR) have been recognized in animal studies. We aimed to investigate sexual dimorphism in human small intestinal mucosal responses to IR.
METHODS: In 16 patients (8 men and 8 women) undergoing pancreaticoduodenectomy, an isolated part of jejunum was subjected to IR. In each patient, intestinal tissue and blood was collected directly after 45 minutes of ischemia without reperfusion (45I-0R), after 30 minutes of reperfusion (45I-30R), and after 120 minutes of reperfusion (45I-120R), as well as a control sample not exposed to IR, to assess epithelial damage, unfolded protein response (UPR) activation, and inflammation.
RESULTS: More extensive intestinal epithelial damage was observed in males compared to females. Intestinal fatty acid binding protein (I-FABP) arteriovenous (V-A) concentrations differences were significantly higher in males compared to females at 45I-0R (159.0 [41.0-570.5] ng/mL vs 46.9 [0.3-149.9] ng/mL). Male intestine showed significantly higher levels of UPR activation than female intestine, as well as higher number of apoptotic Paneth cells per crypt at 45I-30R (16.4% [7.1-32.1] vs 10.6% [0.0-25.4]). The inflammatory response in male intestine was significantly higher compared to females, with a higher influx of neutrophils per villus at 45I-30R (4.9 [3.1-12.0] vs 3.3 [0.2-4.5]) and a higher gene expression of TNF-α and IL-10 at 45I-120R.
CONCLUSION: The human female small intestine seems less susceptible to IR-induced tissue injury than the male small intestine. Recognition of such differences could lead to the development of novel therapeutic strategies to reduce IR-associated morbidity and mortality.

Entities:  

Mesh:

Year:  2020        PMID: 30614877     DOI: 10.1097/SLA.0000000000003167

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  6 in total

1.  Sildenafil as a Rescue Agent Following Intestinal Ischemia and Reperfusion Injury.

Authors:  Hannah M Moore; Natalie A Drucker; Brian D Hosfield; W Chris Shelley; Troy A Markel
Journal:  J Surg Res       Date:  2019-10-17       Impact factor: 2.192

2.  Inhibition of a triggering receptor expressed on myeloid cells-1 (TREM-1) with an extracellular cold-inducible RNA-binding protein (eCIRP)-derived peptide protects mice from intestinal ischemia-reperfusion injury.

Authors:  Naomi-Liza Denning; Monowar Aziz; Mahendar Ochani; Jose M Prince; Ping Wang
Journal:  Surgery       Date:  2020-05-18       Impact factor: 3.982

3.  H151, A SMALL MOLECULE INHIBITOR OF STING AS A NOVEL THERAPEUTIC IN INTESTINAL ISCHEMIA-REPERFUSION INJURY.

Authors:  Molly Kobritz; Timothy Borjas; Vihas Patel; Gene Coppa; Monowar Aziz; Ping Wang
Journal:  Shock       Date:  2022-07-30       Impact factor: 3.533

4.  Fetuin-A exerts a protective effect against experimentally induced intestinal ischemia/reperfusion by suppressing autophagic cell death.

Authors:  Nanees F El-Malkey; Amira E Alsemeh; Wesam Mr Ashour; Nancy H Hassan; Husam M Edrees
Journal:  Exp Biol Med (Maywood)       Date:  2021-03-02

Review 5.  Targeting the Endothelium to Achieve Cardioprotection.

Authors:  Nicolas Herrera-Zelada; Ursula Zuñiga-Cuevas; Andres Ramirez-Reyes; Sergio Lavandero; Jaime A Riquelme
Journal:  Front Pharmacol       Date:  2021-02-02       Impact factor: 5.810

6.  Estradiol Ameliorates Acute Kidney Ischemia-Reperfusion Injury by Inhibiting the TGF-βRI-SMAD Pathway.

Authors:  Lian Ren; Fang Li; Ziyang Di; Yan Xiong; Shichen Zhang; Qing Ma; Xiaoen Bian; Zhiquan Lang; Qifa Ye; Yanfeng Wang
Journal:  Front Immunol       Date:  2022-02-24       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.